Budroni, Sonia
Buricchi, Francesca
Cavallone, Andrea http://orcid.org/0000-0001-5135-363X
Bourguignon, Patricia
Caubet, Magalie
Dewar, Vincent
D’Oro, Ugo http://orcid.org/0000-0002-7657-8605
Finco, Oretta
Garçon, Nathalie
El Idrissi, Mohamed
Janssens, Michel http://orcid.org/0000-0002-8800-9071
Leroux-Roels, Geert
Marchant, Arnaud
Schwarz, Tino
Van Damme, Pierre
Volpini, Gianfranco
van der Most, Robbert
Didierlaurent, Arnaud M.
Burny, Wivine http://orcid.org/0000-0001-8063-4596
Article History
Received: 8 July 2020
Accepted: 9 April 2021
First Online: 21 May 2021
Competing interests
: F.B., O.F., S.B., M.J., P.B., G.V., V.D., M.E.I., M.C., U.D.O., W.B., and R.v.d.M. are employees of the GSK group of companies. A.M.D., W.B., and R.v.d.M. hold shares in the GSK group of companies as part of their employee remuneration. A.M.D. and R.v.d.M. own patents related to AS01. A.C. and A.M.D. were employees of the GSK group of companies at the time of the study. A.M., N.G., G.L.R., P.V.D., T.S. report honoraria from GSK for lecturing, as a member of advisory boards, and conducting clinical trials.